EVOLVA BIOTECH A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About EVOLVA BIOTECH A/S
EVOLVA BIOTECH A/S (CVR number: 25532538) is a company from KØBENHAVN. The company recorded a gross profit of -116.2 kDKK in 2020. The operating profit was -116.4 kDKK, while net earnings were -196.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was -1.2 %, which can be considered poor and Return on Equity (ROE) was -3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 98.3 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. EVOLVA BIOTECH A/S's liquidity measured by quick ratio was 60.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 59 907.65 | ||||
Gross profit | 41 876.13 | 49 857.02 | 2 917.43 | 638.88 | - 116.21 |
EBIT | 182.22 | 187.42 | 109.92 | - 199.70 | - 116.43 |
Net earnings | - 619.53 | - 724.54 | 241.39 | - 187.01 | - 196.81 |
Shareholders equity total | 7 245.56 | 6 521.02 | 6 762.41 | 6 575.39 | 6 378.58 |
Balance sheet total (assets) | 31 563.54 | 21 048.98 | 8 056.91 | 6 577.67 | 6 485.86 |
Net debt | 5 973.57 | -2 815.86 | -96.48 | -1 189.92 | - 100.17 |
Profitability | |||||
EBIT-% | 0.3 % | ||||
ROA | 1.3 % | 1.3 % | 2.0 % | -1.7 % | -1.2 % |
ROE | -8.6 % | -10.5 % | 3.6 % | -2.8 % | -3.0 % |
ROI | 1.7 % | 2.2 % | 4.1 % | -1.9 % | -1.2 % |
Economic value added (EVA) | 182.22 | 109.78 | -34.16 | - 534.60 | - 387.05 |
Solvency | |||||
Equity ratio | 23.0 % | 31.0 % | 83.9 % | 100.0 % | 98.3 % |
Gearing | 161.1 % | 12.9 % | 0.0 % | ||
Relative net indebtedness % | 31.1 % | ||||
Liquidity | |||||
Quick ratio | 0.8 | 1.2 | 6.2 | 2 890.0 | 60.5 |
Current ratio | 0.8 | 1.2 | 6.2 | 2 890.0 | 60.5 |
Cash and cash equivalents | 5 700.47 | 3 653.91 | 97.61 | 1 189.92 | 100.17 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | -3.2 % | ||||
Credit risk | |||||
Credit rating | A | BBB | BBB | B | B |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.